These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19846907)

  • 21. [Celecoxib enhances chemosensitivity of oral cancer cells by blocking cell cycle progression in vitro].
    Liao W; Yan Y; Huang Y; Li W
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):885-8. PubMed ID: 23803204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of celecoxib and doxorubicin increases growth inhibition and apoptosis in acute myeloid leukemia cells.
    Chen C; Xu W; Wang CM
    Leuk Lymphoma; 2013 Nov; 54(11):2517-22. PubMed ID: 23452119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence.
    Narayanan BA; Reddy BS; Bosland MC; Nargi D; Horton L; Randolph C; Narayanan NK
    Clin Cancer Res; 2007 Oct; 13(19):5965-73. PubMed ID: 17908994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of celecoxib treatment over the AKT pathway in head and neck squamous cell carcinoma.
    Abrahão AC; Giudice FS; Sperandio FF; Pinto Junior Ddos S
    J Oral Pathol Med; 2013 Nov; 42(10):793-8. PubMed ID: 23679684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Celecoxib-induced cytotoxic effect is potentiated by inhibition of autophagy in human urothelial carcinoma cells.
    Huang KH; Kuo KL; Ho IL; Chang HC; Chuang YT; Lin WC; Lee PY; Chang SC; Chiang CK; Pu YS; Chou CT; Hsu CH; Liu SH
    PLoS One; 2013; 8(12):e82034. PubMed ID: 24349176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
    Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.
    Mazzanti R; Platini F; Bottini C; Fantappiè O; Solazzo M; Tessitore L
    Biochem Pharmacol; 2009 Jul; 78(1):21-32. PubMed ID: 19447220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Celecoxib inhibits cellular growth, decreases Ki-67 expression and modifies apoptosis in ovarian cancer cell lines.
    Vital-Reyes V; Rodríguez-Burford C; Chhieng DC; Oelschlager DK; Reyes-Fuentes A; Barnes M; Grizzle WE
    Arch Med Res; 2006 Aug; 37(6):689-95. PubMed ID: 16824926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth inhibitory effects of celecoxib in human umbilical vein endothelial cells are mediated through G1 arrest via multiple signaling mechanisms.
    Lin HP; Kulp SK; Tseng PH; Yang YT; Yang CC; Chen CS; Chen CS
    Mol Cancer Ther; 2004 Dec; 3(12):1671-80. PubMed ID: 15634661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
    Lev-Ari S; Zinger H; Kazanov D; Yona D; Ben-Yosef R; Starr A; Figer A; Arber N
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S276-80. PubMed ID: 16507392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined valproic acid and celecoxib treatment induced synergistic cytotoxicity and apoptosis in neuroblastoma cells.
    Chen Y; Tsai YH; Tseng SH
    Anticancer Res; 2011 Jun; 31(6):2231-9. PubMed ID: 21737646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
    Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
    Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2,5-Dimethyl-celecoxib inhibits cell cycle progression and induces apoptosis in human leukemia cells.
    Sobolewski C; Rhim J; Legrand N; Muller F; Cerella C; Mack F; Chateauvieux S; Kim JG; Yoon AY; Kim KW; Dicato M; Diederich M
    J Pharmacol Exp Ther; 2015 Nov; 355(2):308-28. PubMed ID: 26330537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced inhibition of urinary bladder cancer growth and muscle invasion by allyl isothiocyanate and celecoxib in combination.
    Bhattacharya A; Li Y; Shi Y; Zhang Y
    Carcinogenesis; 2013 Nov; 34(11):2593-9. PubMed ID: 23946495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
    Grubbs CJ; Lubet RA; Koki AT; Leahy KM; Masferrer JL; Steele VE; Kelloff GJ; Hill DL; Seibert K
    Cancer Res; 2000 Oct; 60(20):5599-602. PubMed ID: 11059745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of PGE2 by physiologic levels of celecoxib is not sufficient to induce apoptosis or inhibit cell proliferation in human colon carcinoma cell lines.
    Lev-Ari S; Kazanov D; Liberman E; Ben-Yosef R; Arber N
    Dig Dis Sci; 2007 Apr; 52(4):1128-33. PubMed ID: 17342386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
    Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
    J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CpG Oligodeoxynucleotides Induces Apoptosis of Human Bladder Cancer Cells via Caspase-3-Bax/Bcl-2-p53 Axis.
    Luo Y; Fu X; Ru R; Han B; Zhang F; Yuan L; Men H; Zhang S; Tian S; Dong B; Meng M
    Arch Med Res; 2020 Apr; 51(3):233-244. PubMed ID: 32139108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9.
    Shishodia S; Aggarwal BB
    Cancer Res; 2004 Jul; 64(14):5004-12. PubMed ID: 15256475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.